Azenta Life Sciences Announces Leadership Transition to Accelerate Gene Synthesis Strategy and Multiomics Execution

B BURLINGTON, Mass., April 7, 2026 /PRNewswire/ — Azenta, Inc. (Nasdaq: AZTA) today announced the appointment of Trey Martin as President of its Multiomics business, effective…
posteditor
posteditor
Articles: 16137

Other News